Raymond James & Associates’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-159,511
| Closed | -$110K | – | 3965 |
|
|
2020
Q4 | $110K | Sell |
159,511
-24,370
| -13% | -$16.8K | ﹤0.01% | 3494 |
|
|
2020
Q3 | $414K | Sell |
183,881
-599,569
| -77% | -$1.35M | ﹤0.01% | 2742 |
|
|
2020
Q2 | $2.81M | Buy |
783,450
+343,854
| +78% | +$1.23M | ﹤0.01% | 1521 |
|
|
2020
Q1 | $1.67M | Buy |
439,596
+51,968
| +13% | +$197K | ﹤0.01% | 1672 |
|
|
2019
Q4 | $1.17M | Buy |
+387,628
| New | +$1.17M | ﹤0.01% | 2175 |
|